Roche Alzheimer’s Push May Gain From Obama Brain-Mapping Plan

Roche Alzheimer’s Push May Gain From Obama Brain-Mapping Plan

Gianluca Colla/Bloomberg

Roche AG has 16 drugs in development for neurological disorders, including four for Alzheimer's disease and two for autism.